• A Novel Strategy for Glioblastoma Treatment by Natural Bioactive Molecules Showed a Highly Effective Anti-Cancer Potential
• A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine
• Accidental Encounter of Repair Intermediates in Alkylated DNA May Lead to Double-Strand Breaks in Resting Cells
• Activity Measure for Post-Acute care (AM-PAC) scores predict Short and Long-Term outcomes following glioblastoma resection
• An Extremely Rare Case of Collision Tumor: A Craniopharyngioma Coexists Pilocytic Astrocytoma
• Anti-tumor effect of innovative tumor treatment device OM-100 through enhancing anti-PD-1 immunotherapy in glioblastoma growth
• Association between dichotomized VASARI feature and overall survival in glioblastoma patients: a single-institution propensity score matching analysis
• Astrocytes and the tumor microenvironment inflammatory state dictate the killing of glioblastoma cells by Smac mimetic compounds
• Beyond childhood: exploring the state of transitional care in pediatric pilocytic astrocytoma
• Brazilian pediatric patients with gliomas: treatment characteristics and survival outcomes
• Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone
• Cerebrospinal Fluid Seeding Versus Inflammation in Setting of Ventriculoperitoneal Shunt as a Potential Cause for Distant Recurrence of Glioblastoma
• Changes in perfusion and permeability in glioblastoma model induced by the anti-angiogenic agents cediranib and thalidomide
• Combination chemotherapy via poloxamer 188 surface-modified PLGA nanoparticles that traverse the blood-brain-barrier in a glioblastoma model
• Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance
• Comparing nnU-Net and deepflash2 for Histopathological Tumor Segmentation
• Contemporary Prognostic Signatures and Refined Risk Stratification of Gliomas: An Analysis of 4,400 Tumors
• Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma
• Deguelin inhibits the glioblastoma progression through suppressing CCL2/NFκB signaling pathway
• Desmoplastic infantile astrocytoma/ ganglioglioma in a pediatric onset multiple sclerosis patient: A case report
• Early High-Grade Transformation of IDH-Mutant Central Nervous System WHO Grade 2 Astrocytoma: A Case Report
• Effect of Ferulic Acid Loaded in Nanoparticle on Tissue Transglutaminase Expression Levels in Human Glioblastoma Cell Line
• Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation
• Endosome-microautophagy targeting chimera (eMIATAC) for targeted proteins degradation and enhance CAR-T cell anti-tumor therapy
• EphA3 CAR T cells are effective against glioblastoma in preclinical models
• Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS tumours
• Evolution of phenotypic plasticity leads to tumor heterogeneity with implications for therapy
• Excessive lipid production shapes glioma tumor microenvironment
• First independent validation of the proton-boron capture therapy concept
• Focused ultrasound blood-brain barrier disruption in high-grade gliomas: Scoping review of clinical studies
• FOSL2-mediated transcription of ISG20 induces M2 polarization of macrophages and enhances tumorigenic ability of glioblastoma cells
• Fractional tumor burden maps increase the confidence of reading brain MR perfusion
• Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma
• GDNF/GFRA1 signaling contributes to chemo- and radioresistance in glioblastoma
• Genomics and proteomics to determine novel molecular subtypes and predict the response to immunotherapy and the effect of bevacizumab in glioblastoma
• Glioma lateralization: Focus on the anatomical localization and the distribution of molecular alterations (Review)
• Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma
• Histopathological Spectrum of Gliomas and Its Immunohistochemical Correlation in a Tertiary Care Setup
• Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors
• Identification and validation of miRNA-target genes network in pediatric brain tumors
• Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study
• Immunomodulatory signalling networks in glioblastoma multiforme: a comprehensive review of therapeutic approaches
• Inhibiting interferon-γ induced cancer intrinsic TNFRSF14 elevation restrains the malignant progression of glioblastoma
• Inhibition of GPR68 kills glioblastoma in zebrafish xenograft models
• Integrative single-cell and bulk transcriptome analyses identify a distinct pro-tumor macrophage signature that has a major prognostic impact on glioblastomas
• Inter-subject cerebrovascular variability: a source of uncertainty for dose calculation to circulating blood cells for glioblastoma patients treated with modern radiotherapy techniques
• Interleukin 4 and cancer resistance in glioblastoma multiforme
• Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
• Intraoperative mapping of epileptogenic foci and tumor infiltration in neuro-oncology patients with epilepsy
• Intratumoral Cell Heterogeneity in Patient-Derived Glioblastoma Cell Lines Revealed by Single-Cell RNA-Sequencing
• Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis
• Kinetic Trajectories of Glucose Uptake in Single Cancer Cells Reveal a Drug-Induced Cell-State Change Within Hours of Drug Treatment
• Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood-brain-barrier and glioblastoma stem cells
• Lactylation: Linking the Warburg effect to DNA damage repair
• Living with glioblastoma - the need for integrated support based on experiences of chaos, loss of autonomy, and isolation in both patients and their relatives
• Metabolic reprogramming of poly(morpho)nuclear giant cells determines glioblastoma recovery from doxorubicin-induced stress
• Metamorphopsia with SMART Syndrome: A Case Report
• Metastasis-enhancing protein KITENIN confers temozolomide resistance on glioblastoma with unmethylated MGMT via upregulation of cancer stem cell makers
• Mucin-Rich Brain Metastasis May Show the T2-FLAIR Mismatch Sign: A Case Report and Literature Review
• Multi-omics and pharmacological characterization of patient-derived glioma cell lines
• Multiparametric whole-body MRI of patients with neurofibromatosis type I: spectrum of imaging findings
• Navigating glioblastoma complexity: the interplay of neurotransmitters and chromatin
• Next-generation vaccines are showing promise against glioblastoma
• Noninvasive prediction of BRAF V600E mutation status of pleomorphic xanthoastrocytomas with MRI morphologic features and diffusion-weighted imaging
• NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation
• Pan-cancer analysis identifies venous thromboembolism-related genes F3, PLAT, and C1S as potential prognostic biomarkers for glioblastoma and lower grade glioma
• Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF-Fusion pilocytic astrocytoma
• Potential of GSPT1 as a novel target for glioblastoma therapy
• Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis
• Primary mismatch repair-deficient IDH-mutant astrocytoma in child: Unusual entity
• Progesterone boosts abiraterone-driven target and NK cell therapies against glioblastoma
• PTBP1-mediated repression of neuron-specific CDC42 splicing constitutes a genomic alteration-independent, developmentally conserved vulnerability in IDH-wildtype glioblastoma
• Racial and social-economic inequalities in systemic chemotherapy use among adult glioblastoma patients following surgery and radiotherapy
• Rapid postradiation malignant transformation of a pilocytic astrocytoma in an adult with neurofibromatosis type 1: illustrative case
• Real-time estimation of the optimal coil placement in transcranial magnetic stimulation using multi-task deep learning
• Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome
• Revisiting gliomatosis cerebri in adult-type diffuse gliomas: a comprehensive imaging, genomic and clinical analysis
• Rosettes and pseudorosettes in veterinary neuropathology
• S100A9, as a potential predictor of prognosis and immunotherapy response for GBM, promotes the malignant progression of GBM cells and migration of M2 macrophages
• Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial
• SelK promotes glioblastoma cell proliferation by inhibiting β-TrCP1 mediated ubiquitin-dependent degradation of CDK4
• Solitary isolated disseminations of glioblastoma to sellar and suprasellar regions: two case reports
• Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies
• Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy
• Stepwise-targeting and hypoxia-responsive liposome AMVY@NPs carrying siYAP and verteporfin for glioblastoma therapy
• Survival After Newly-Diagnosed High-Grade Glioma Surgery: What Can We Learn From the French National Healthcare Database?
• T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant
• Targeted opening of the blood-brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma
• The complex molecular epileptogenesis landscape of glioblastoma
• Thymoquinone reversed doxorubicin resistance in U87 glioblastoma cells via targeting PI3K/Akt/mTOR signaling
• TiO₂-ZnPc nanoparticles functionalized with folic acid as a target photosensitizer for photodynamic therapy against glioblastoma cells
• Transcriptomics-based characterization of the immuno-stromal microenvironment in pediatric low-grade glioma
• Triggering of endoplasmic reticulum stress via ATF4-SPHK1 signaling promotes glioblastoma invasion and chemoresistance
• Understanding spinal cord astrocytoma: Molecular mechanism, therapy, and comprehensive management
• Unveiling hierarchy and spatial distribution of O⁶-methylguanine-DNA methyltransferase promoter methylation in World Health Organization grade 2-3 gliomas
• Urinary D-asparagine level is decreased by the presence of glioblastoma
• Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign
• VEGFA contributes to tumor property of glioblastoma cells by promoting differentiation of myeloid-derived suppressor cells
• Virtual reality: a game-changer in the diagnosis and surgical planning of astrocytoma grade III: a case report
• When playing the NK cell therapy card in glioblastoma, you can't beat interleukin-21